Grifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulins

Corporate Breaking News

Home : Grifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulins

Mar 09 2021	Grifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulins
BARCELONA, Spain, March 9, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P; NASDAQ: GRFS), a global healthcare company with a proven track record of more than 100 years dedicated to improving the health and well-being of people worldwide, today announced the closing of its agreement...


Source:https://www.prnewswire.com:443/news-releases/grifols-reinforces-its-innovation-strategy-after-completing-the-acquisition-of-gigagen-to-boost-a-novel-method-to-generate-a-wide-range-of-immunoglobulins-301243039.html

Related News
» iQIYI Ushers in Next-Generation of Entertainment with Launch of China's First Extended Reality (XR) Cloud Show » GLOW SHENZHEN 2020 concludes with the goal of building China's tech-based art IP